Shanghai Shyndec Pharmaceutical Co., Ltd.SSE: 600420

Earnings Preannouncement for Q1 2026

Apr 11, 2026 · Issued by Shanghai Shyndec Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Apr 11, 2026

On 6ix: 6ix.com/news/earnings-preannouncement-for-q1-2026-1

Earnings Preannouncement for Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Shanghai Shyndec Pharmaceutical Co., Ltd. on 6ix

Earlier from Shanghai Shyndec Pharmaceutical

Announcement on Voluntary Information Disclosure of Wholly-owned Subsidiary's Drug Passing Consistency Evaluation for Generic DrugsApr 4
Announcement on Estimated Daily Related Party Transactions in 2026Mar 28
by Holding SubsidiaryMar 25
Announcement on Obtaining Drug Registration Certificate by Wholly-owned SubsidiaryMar 4
Announcement on Wholly-owned Sub-subsidiary Obtaining Approval for Marketing of Chemical APIsFeb 25

Later from Shanghai Shyndec Pharmaceutical

Announcement on Progress in Providing Guarantees for SubsidiariesApr 16
Report for Q1 2026Apr 30
Announcement on Resolutions of the 2025 Annual General MeetingMay 9
Announcement on Wholly-owned Subsidiary's Drug Substance Obtaining Indian Registration CertificateMay 12
Announcement on Obtaining Drug Registration CertificateMay 22

All Shanghai Shyndec Pharmaceutical news releases

Follow Shanghai Shyndec Pharmaceutical into a list and get an email when it puts out news.

Follow Shanghai Shyndec Pharmaceutical